Advertisement
News
Subscribe to MDT Magazine News

Covidien Receives FDA Premarket Approval for Pipeline(R) Embolization Device(3)

April 6, 2011 4:39 pm | by Covidien | Comments

MANSFIELD, Mass., Apr 06, 2011 (BUSINESS WIRE) --Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that it received Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Pipeline(R) Embolization Device, indicated for the...

TOPICS:

Covidien Receives FDA Premarket Approval for Pipeline(R) Embolization Device(2)

April 6, 2011 4:37 pm | Comments

MANSFIELD, Mass., Apr 06, 2011 (BUSINESS WIRE) --Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that it received Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Pipeline(R) Embolization Device, indicated for the...

Hypothermia proven to improve survival and outcomes following out-of-hospital cardiac arrest

April 6, 2011 2:33 pm | by EurekAlert | Comments

(Mary Ann Liebert, Inc./Genetic Engineering News) The successful use and evaluation of therapeutic hypothermia to improve survival and reduce the risk of neurological consequences following an out-of-hospital heart attack are explored in the premier issue of Therapeutic Hypothermia and...

TOPICS:
Advertisement

ImmuCor 3Q profit rises on sales

April 6, 2011 1:45 pm | by The Associated Press | Comments

Blood-testing equipment maker ImmuCor Inc. said Wednesday its profit grew 13 percent in its fiscal third quarter on higher sales of instruments and testing products.The results and the company's new fiscal 2011 profit and sales guidance topped analysts' expectations and ImmuCor's shares jumped...

AVI BioPharma Announces Exercise of Underwriters' Over-Allotment Option and Closing of Public Offering of Common Stock

April 6, 2011 12:45 pm | by The Associated Press | Comments

AVI BioPharma, Inc. (NASDAQ: AVII) today announced that, in connection with its previously announced public offering, the underwriters have exercised in full their over-allotment option to purchase an additional 3,000,000 shares of AVI BioPharma's common stock at $1.50 per share, less...

What the world needs now? More wisdom

April 6, 2011 12:39 pm | by EurekAlert | Comments

(Concordia University) Concordia researchers have compiled data to assess how wisdom shapes life. The result? Wisdom has an impact on how people cope in situations and whether they are more or less satisfied with life.

TOPICS:

New England Biolabs, Sequenom form licensing deal

April 6, 2011 11:38 am | by Mass High Tech: The Journal of New England Technology | Comments

New England Biolabs Inc. (NEB) has signed a licensing and co-marketing deal with Sequenom Inc. to commercialize the EpiMark Methylated DNA Enrichment Kit.

TOPICS:

International organizations join forces to promote cardiovascular health

April 6, 2011 11:38 am | by EurekAlert | Comments

(European Society of Cardiology) This year's EuroPRevent meeting, April 14-16, is taking full advantage of its Geneva location and the close proximity to the European Headquarters of the World Health Organization, the World Heart Federation, the United European Football Association...

TOPICS:
Advertisement

CMU's Takeo Kanade wins ACM/AAAI Award for career contributions to computer vision, robotics

April 6, 2011 11:38 am | by EurekAlert | Comments

(Carnegie Mellon University) The Association for Computing Machinery has named Takeo Kanade, the U.A. and Helen Whitaker University Professor of Computer Science and Robotics at Carnegie Mellon University, the 2010 winner of the ACM/AAAI Allen Newell Award for contributions to...

TOPICS:

Lilly Confirms Date and Conference Call for First-Quarter 2011 Financial Results Announcement

April 6, 2011 11:37 am | by Bio-Medicine.Org | Comments

INDIANAPOLIS, April 6, 2011 /- Eli Lilly and Company (NYSE: LLY ) will announce its financial results for the first quarter of 2011 on Monday, April 18, 2011.  Lilly will also conduct a conference call on that day with the investment community and media to further detail the...

TOPICS:

Quest Diagnostics Honored for Diagnostic Innovation at 2011 Edison Awards

April 6, 2011 11:32 am | by Bio-Medicine.Org | Comments

MADISON, N.J., April 6, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced that the Simplexa™ molecular test on the 3M™ Integrated Cycler was honored with a bronze award for best...

TOPICS:

High levels of toxic compounds found on coasts of West Africa

April 6, 2011 9:40 am | by EurekAlert | Comments

(FECYT - Spanish Foundation for Science and Technology) An international team of scientists has found very high levels of polychlorinated biphenyls (PCBs) along the coasts of West Africa. Production of these extremely toxic compounds has been banned in Europe and the United States...

TOPICS:

Texas Independent Drugstore Lobby (Continues) Putting Profits Ahead of Patients

April 6, 2011 9:38 am | by Bio-Medicine.Org | Comments

WASHINGTON, April 6, 2011 /PRNewswire-USNewswire/ -- To help reduce state Medicaid spending and save taxpayers $84 million, Governor Rick Perry (R) has proposed that the program's prescription drug benefits be operated more like those in the private sector that are more affordable and...

TOPICS:

Smith & Nephew Endoscopy unit marks medical device milestone

April 6, 2011 9:36 am | by Mass High Tech: The Journal of New England Technology | Comments

The Andover-based Endoscopy division of Smith & Nephew plc, a medical devices firm with headquarters in London, has had its flagship product, the TRUCLEAR System, hit 30,000 procedures.

TOPICS:

LabCorp in $85.4M deal for DNA testing company

April 6, 2011 8:45 am | by The Associated Press | Comments

Laboratory Corp. of America Holdings said Wednesday it agreed to acquire all shares of DNA and paternity testing services company Orchid Cellmark Inc. for $85.4 million, or $2.80 per share.LabCorp, a clinical lab services company based in Burlington, N.C., said it expects the deal to close...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading